You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Project in First-degree Relatives of Myeloma Patient - The

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
  • Sample of Blood
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 31, 2023

Relapsed or Refractory Multiple Myeloma Trial in Tianjin (YTS104 Cells injection)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • YTS104 Cells injection
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

Multiple Myeloma Trial in São Paulo (Single-dose involved-site radiotherapy)

Recruiting
  • Multiple Myeloma
  • Single-dose involved-site radiotherapy
  • São Paulo, Sao Paulo, Brazil
    University of Sao Paulo
Aug 9, 2023

Multiple Myeloma Trial in Paris (Idecabtagene vicleucel, Not treated)

Active, not recruiting
  • Multiple Myeloma
  • Idecabtagene vicleucel
  • Not treated
  • Paris, France
    DESCAR-T Registry
Nov 27, 2023

Multiple Myeloma Trial in Los Angeles (Penguin Cold Cap)

Recruiting
  • Multiple Myeloma
  • Penguin Cold Cap
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jul 27, 2023

Multiple Myeloma Trial in Wuhan (Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells)

Recruiting
  • Multiple Myeloma
  • Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 11, 2023

Smoldering Multiple Myeloma Trial (Selinexor)

Not yet recruiting
  • Smoldering Multiple Myeloma
  • (no location specified)
Oct 27, 2022

Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • pegylated recombinant human granulocyte-colony stimulating factor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Sep 23, 2023

Multiple Myeloma Trial in Suzhou (Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
May 3, 2023

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Multiple Myeloma Trial in Roma, Rome (ChIP-seq, NGS, ATAC-seq)

Recruiting
  • Multiple Myeloma
  • ChIP-seq, NGS, ATAC-seq
  • Roma, Italy
  • +1 more
May 24, 2023

Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

Not yet recruiting
  • Multiple Myeloma
  • Renal Failure
  • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
  • Augusta, Georgia
    Georgia Cancer Center-Augusta University
Nov 16, 2023

Multiple Myeloma Trial in Rochester (behavioral, other, procedure)

Not yet recruiting
  • Multiple Myeloma
  • Supportive Care (home-based physical activity)
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Myeloma Multiple, Myeloma, Refractory Multiple Myeloma Trial in Brooklyn, New York (Selinexor, Clarithromycin, Pomalidomide)

Terminated
  • Myeloma Multiple
  • +2 more
  • Brooklyn, New York
  • +1 more
Jan 24, 2023

Multiple Myeloma Trial in Augusta (Lenalidomide, Vitamin D - Intensified, Vitamin D - Therapeutic)

Not yet recruiting
  • Multiple Myeloma
  • Augusta, Georgia
    Georgia Cancer Center at Augusta University
Apr 26, 2023

Medicine Called Elranatamab in People With Relapsed Refractory

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 30, 2023

Learn How Triple Class Refractory Multiple Myeloma Are Treated

Not yet recruiting
  • Relapse Multiple Myeloma
  • Refractory Multiple Myeloma
    • (no location specified)
    Feb 15, 2023

    Multiple Myeloma Cells From miRNAs Released From B Cells, and

    Recruiting
    • Multiple Myeloma
      • Aviano, Pordenone, Italy
        Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
      Nov 23, 2023

      Smoldering Multiple Myeloma Trial in Rochester (Denosumab)

      Active, not recruiting
      • Smoldering Multiple Myeloma
      • Rochester, New York
        University of Rochester
      Oct 3, 2022

      Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

      Not yet recruiting
      • Relapsed/ Refractory Multiple Myeloma
      • GC012F
      • (no location specified)
      Apr 28, 2023

      Host Microbiota and Il-17 in Favoring Multiple Myeloma

      Recruiting
      • Multiple Myeloma
        • Milan, Milano, Italy
          IRCCS Ospedale San Raffaele
        Jan 26, 2023

        Relapsed or Refractory Multiple Myeloma Trial (Talquetamab)

        Available
        • Relapsed or Refractory Multiple Myeloma
        • (no location specified)
        Mar 6, 2023

        Relapsed or Refractory Multiple Myeloma Trial in Tianjin (QLS32015)

        Recruiting
        • Relapsed or Refractory Multiple Myeloma
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Jun 24, 2023

        Relapsed/Refractory Multiple Myeloma Trial in Suzhou (Mitoxantrone HCl liposome/Dexamethasone/daratumumab)

        Recruiting
        • Relapsed/Refractory Multiple Myeloma
        • Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab
        • Suzhou, Jiangsu, China
          Second Affiliated Hospital of Soochow University
        May 4, 2023

        Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

        Not yet recruiting
        • Multiple Myeloma
        • +2 more
        • Drug and medical device
        • Poitiers, France
          CHU Poitiers
        Jun 1, 2023